Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The ankyrin repeat domain 18A pseudogene is a genomic sequence that shares homology with the ankyrin repeat domain 18A gene but lacks protein-coding potential due to disabling mutations or missing regulatory elements. Ankyrin repeat domains are protein motifs involved in protein–protein interactions and are present in proteins linked to diverse cellular functions such as signal transduction and cytoskeletal regulation[5][7]. However, as a pseudogene, this locus does not produce a functional protein and is not considered a viable therapeutic target. While some pseudogenes may retain regulatory roles at the RNA level, there is no current evidence that this specific pseudogene has such functions or clinical significance[2][4][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ankyrin repeat domain 18A pseudogene.